CAS 81167-22-8

2-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-1-ethyl-1H-imidazole hydrochloride

CAS : 81167-22-8

Formule : C₁₄H₁₇ClN₂O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 280.7500

Ref: IN-DA00GAID

Imiloxan hydrochloride

CAS : 81167-22-8

Imiloxan hydrochloride is a diagnostic agent that is used to diagnose Parkinson's disease and other neurological disorders. Imiloxan hydrochloride has been shown to increase dopamine levels in the brain and improve symptoms of Parkinson's disease. Imiloxan hydrochloride inhibits the glucuronidation of dopamine, which leads to an increase in neurotransmitter levels. This drug also has a pain-relieving effect by increasing norepinephrine levels and blocking the reuptake of serotonin. Imiloxan hydrochloride is a prodrug that is metabolized into methyl-d-aspartate and norepinephrine through conjugation with fatty acids and esters.

Formule : C₁₄H₁₇ClN₂O₂

Degré de pureté : Min. 95%

Masse moléculaire : 280.75 g/mol

Ref: 3D-GDA16722

Imiloxan hydrochloride

CAS : 81167-22-8

Imiloxan hydrochloride is an α2-adrenoceptor antagonist.

Formule : C₁₄H₁₇ClN₂O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 280.75

Ref: TM-T22861